ISFP & PA Workshop 2022

Lys Therapeutics announces to attend the 3rd Joint Meeting of the International Society of Fibrinolysis and Proteolysis and the Plasminogen Activation Workshop (“ISFP and PA Workshop”), happening this year in #Caen, 5-9 September 2022.

Dr. Manuel BLANC, Pr. Denis VIVIEN, Dr. Flavie Lesept, Dr. Fanny Potzeha, Dr. Jean-Baptiste BERTRAND and all Lys Therapeutics’ team is happy to meet you there.

💪 All together against Stroke and its dramatic consequences.

—
https://www.cyceron.fr/isfp/index.php?page=programme

—

With bb@c, Blood and Brain Caen normandie and CYCERON

#ISFP #Stroke #neurosciences #clinicaltrials #Research #PublicPrivatePartnership #Collaboration #deeptech #biotech #healthcare #lifesciences #CNS #brain #NeurologicalDiseases #NeurovascularDisorders #stroke #dementia #innovation #MedicalNeeds #LysTherapeutics #biotherapy #Glunomab #Glunozumab

Oral presentation – ISFP 2022

🔬🧠 “Lys Therapeutics, first-in-class biotherapies against neurological disorders”

🎤 Dr. Manuel BLANC, CEO of Lys Therapeutics is presenting on September 7, 2022 during the 3rd Joint Meeting of the International Society of Fibrinolysis and Proteolysis and the Plasminogen Activation Workshop (“ISFP and PA Workshop”), new promising preclinical data with Lys Therapeutics’s lead candidate Glunomab / Glunozumab in ischemic stroke.

With bb@c, Blood and Brain Caen normandie and CYCERON